Last10K.com

Minerva Neurosciences, Inc. (NERV) SEC Filing 8-K Material Event for the period ending Thursday, March 22, 2018

Minerva Neurosciences, Inc.

HISTORY TOOLS
CIK: 1598646 Ticker: NERV

View differences made from one to another to evaluate Minerva Neurosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Minerva Neurosciences, Inc..

Continue

Assess how Minerva Neurosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Minerva Neurosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Minerva Neurosciences, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: NERV
CIK: 1598646
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-091355
Submitted to the SEC: Thu Mar 22 2018 7:32:09 AM EST
Accepted by the SEC: Thu Mar 22 2018
Period: Thursday, March 22, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/nerv/0001193125-18-091355.htm